Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision marker was updated from v3.5.0 to v3.5.3, reflecting a maintenance/version update rather than a change to any clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-26T15:17:32.000Z thumbnail image
  4. Check
    53 days ago
    Change Detected
    Summary
    The website revision label was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:51:00.000Z thumbnail image
  5. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No other visible content changes were detected.
    Difference
    0.1%
    Check dated 2026-03-06T18:57:41.000Z thumbnail image
  6. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no changes to study content or data were detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:48:09.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Only a page revision label was updated: v3.4.1 was added and v3.4.0 removed; there are no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:18:12.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    Added glossary toggle options (Show glossary, Hide glossary) and new QC/versioning metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-22T18:20:19.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.